243 related articles for article (PubMed ID: 12888804)
21. Differential effects of enrichment on learning and memory function in NR2B transgenic mice.
Tang YP; Wang H; Feng R; Kyin M; Tsien JZ
Neuropharmacology; 2001 Nov; 41(6):779-90. PubMed ID: 11640933
[TBL] [Abstract][Full Text] [Related]
22. Orphanin FQ (nociceptin) modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli, and blocks the substance P-induced facilitation of N-methyl-D-aspartate-evoked responses.
Wang XM; Zhang KM; Long LO; Mokha SS
Neuroscience; 1999; 93(2):703-12. PubMed ID: 10465454
[TBL] [Abstract][Full Text] [Related]
23. Enhanced CaMKII activity and spatial cognitive function in SAMP6 mice.
Takahashi E; Niimi K; Itakura C
Behav Neurosci; 2009 Jun; 123(3):527-32. PubMed ID: 19485558
[TBL] [Abstract][Full Text] [Related]
24. Pavlovian fear conditioning regulates Thr286 autophosphorylation of Ca2+/calmodulin-dependent protein kinase II at lateral amygdala synapses.
Rodrigues SM; Farb CR; Bauer EP; LeDoux JE; Schafe GE
J Neurosci; 2004 Mar; 24(13):3281-8. PubMed ID: 15056707
[TBL] [Abstract][Full Text] [Related]
25. Nociceptin/orphanin FQ: role in nociceptive information processing.
Yamamoto T; Nozaki-Taguchi N; Sakashita Y; Kimura S
Prog Neurobiol; 1999 Apr; 57(5):527-35. PubMed ID: 10215100
[TBL] [Abstract][Full Text] [Related]
26. Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.
Narita M; Mizoguchi H; Oji DE; Dun NJ; Hwang BH; Nagase H; Tseng LF
Br J Pharmacol; 1999 Nov; 128(6):1300-6. PubMed ID: 10578145
[TBL] [Abstract][Full Text] [Related]
27. Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation.
Zhao D; Watson JB; Xie CW
J Neurophysiol; 2004 Nov; 92(5):2853-8. PubMed ID: 15212428
[TBL] [Abstract][Full Text] [Related]
28. Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat.
Champion HC; Pierce RL; Kadowitz PJ
Regul Pept; 1998 Nov; 78(1-3):69-74. PubMed ID: 9879748
[TBL] [Abstract][Full Text] [Related]
29. A role for hippocampal PSA-NCAM and NMDA-NR2B receptor function in flavonoid-induced spatial memory improvements in young rats.
Rendeiro C; Foley A; Lau VC; Ring R; Rodriguez-Mateos A; Vauzour D; Williams CM; Regan C; Spencer JP
Neuropharmacology; 2014 Apr; 79(100):335-44. PubMed ID: 24333331
[TBL] [Abstract][Full Text] [Related]
30. Close linkage between calcium/calmodulin kinase II alpha/beta and NMDA-2A receptors in the lateral amygdala and significance for retrieval of auditory fear conditioning.
Moriya T; Kouzu Y; Shibata S; Kadotani H; Fukunaga K; Miyamoto E; Yoshioka T
Eur J Neurosci; 2000 Sep; 12(9):3307-14. PubMed ID: 10998114
[TBL] [Abstract][Full Text] [Related]
31. Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.
Hawes BE; Fried S; Yao X; Weig B; Graziano MP
J Neurochem; 1998 Sep; 71(3):1024-33. PubMed ID: 9721727
[TBL] [Abstract][Full Text] [Related]
32. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family.
Mogil JS; Pasternak GW
Pharmacol Rev; 2001 Sep; 53(3):381-415. PubMed ID: 11546835
[TBL] [Abstract][Full Text] [Related]
33. Nociceptin, an endogenous ligand for the ORL1 receptor, has vasodilator activity in the hindquarters vascular bed of the rat.
Czapla MA; Champion HC; Kadowitz PJ
Peptides; 1997; 18(6):793-5. PubMed ID: 9285926
[TBL] [Abstract][Full Text] [Related]
34. Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors.
Schlicker E; Werthwein S; Kathmann M; Bauer U
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):418-22. PubMed ID: 9826063
[TBL] [Abstract][Full Text] [Related]
35. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat.
Champion HC; Kadowitz PJ
Life Sci; 1997; 60(16):PL 241-5. PubMed ID: 9096263
[TBL] [Abstract][Full Text] [Related]
36. Nociceptin/orphanin FQ knockout mice display up-regulation of the opioid receptor-like 1 receptor and alterations in opioid receptor expression in the brain.
Clarke S; Chen Z; Hsu MS; Hill RG; Pintar JE; Kitchen I
Neuroscience; 2003; 117(1):157-68. PubMed ID: 12605902
[TBL] [Abstract][Full Text] [Related]
37. Two C-terminal amino acids, Ser(334) and Ser(335), are required for homologous desensitization and agonist-induced phosphorylation of opioid receptor-like 1 receptors.
Wang HL; Kuo YL; Hsu CY; Huang PC; Li AH; Chou AH; Yeh TH; Chen YL
Cell Signal; 2006 May; 18(5):670-8. PubMed ID: 16019191
[TBL] [Abstract][Full Text] [Related]
38. Intradermal nociceptin elicits itch-associated responses through leukotriene B(4) in mice.
Andoh T; Yageta Y; Takeshima H; Kuraishi Y
J Invest Dermatol; 2004 Jul; 123(1):196-201. PubMed ID: 15191560
[TBL] [Abstract][Full Text] [Related]
39. Nociceptin (orphanin FQ), an endogenous ligand for the QRL1 (opioid-receptor-like1) receptor; modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli.
Wang XM; Zhang KM; Mokha SS
J Neurophysiol; 1996 Nov; 76(5):3568-72. PubMed ID: 8930296
[TBL] [Abstract][Full Text] [Related]
40. Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro.
Vaughan CW; Connor M; Jennings EA; Marinelli S; Allen RG; Christie MJ
J Physiol; 2001 Aug; 534(Pt 3):849-59. PubMed ID: 11483714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
